Bicycle Therapeutics Statistics
NASDAQ: BCYCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.90-0.15 (-4.92%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Bicycle Therapeutics by the numbers
Bicycle Therapeutics has a market capitalization of $203.3 million based on 50.66M shares outstanding. With trailing EPS of $-2.03, Bicycle Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.6% below its 50-day average and 33.1% below its 200-day average.
Average daily trading volume is 444.72K shares, or about $1.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BCYC valuation vs. peer median
| Metric | BCYC | Peer median | Difference |
|---|---|---|---|
| Market cap | $203.27M | $199.89M | +2% |
| Avg. volume | 444.72K | 560.96K | -21% |
Peer median across 8 companies: FTH, DRUG, NGEN, VNDA, BIOA, YARW, CYPH, ACIU.
Valuation
- Market cap
- $203.27M
- Price / sales (latest FY)
- 2.80
- EPS (TTM)
- $-2.03
- Shares outstanding
- 50.66M
Price and trading
- Previous close
- 3.05
- Open
- 2.99
- Day range
- 2.85 – 3.00
- 52-week range
- 2.85 – 7.83
- 52-week change
- -54.11%
- Beta
- —
- Volume
- 1.02M
- Average volume
- 444.72K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 203.27M
- Forward Pe
- -1.21
- Eps
- -2.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.83
- Week52 Low
- 2.85
- Avg Volume
- 444.72K
- Shares Outstanding
- 50.66M
- Ma50
- 3.61
- Ma200
- 4.33
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -62.96%
- Pct From52w Low
- 1.75%